12-03-2024
Right back on resistance level again.
Strong BUY for the next bounce.
....or TAKEOVER
12-01-2024
If you say it enough times I think it'll happen you know.....
Unfortunately or fortunately depending on your viewpoint Mr market tends to do the opposite...
It's just so effin predictable...
"Ooooooh price is falling placing coming blah blah blah.....'
Or
"Oooooh price is shooting up must be takeover yadda yadda yadda....'
Change the f**kin record FFs!
05-01-2024
Beg to differ - Bio/Med Tech M&A are forecast to be on a recovery trend in 2024 after a difficult few years. What better target than Angle ?
Having said that I hope they get to plough their own field but there's no room for sentiment & let's be brutally honest - the tech would reach & benefit more patients all the sooner as a result of a takeover. Angle are in a race to develop as much as they can in filling up the menu of content.
My hope is that they get to realise their potential - others will have their own preferences.
I am giving my opinion. I may buy in when it drops from this SP rise which IMO is based on nothing substantial. Keeping an eye on a potential investment is permitted surely in a democracy.Only cynical pumpers can take offence at rational discourse.I am neither short nor long. I have been long, but never short. I donât see enough to reinvest YET. This was a reasonable speculation (gamble) at 11 p but without revenue growth greatly in excess of what is shown so far it, in the memorably words of a former medical colleague, has âone foot in the grave and the other on a slippery banana.âSurely its long term value will attract a big pharma investment or takeover?
260,000,000 shares in issue; 18,000,000 traded so far today, but mainly small quantities.In November they said revenues had been slow to build since FDA approval; in December they changed their broker.There is a Proactive âeventâ next week; Proactive is the AIM propaganda channel on which I have seen Tim McCarthy (Immupharma, another pump and dump pharma) too often.This move is akin to an oil company spiking on announcement drilling will take place in six months.Itâs not an oil strike.That would be a large pharma (tens of millions) contract, a takeover or more futuristic, routine use of Anglesâ tests by oncologists. The latter will require many trial successes showing that changing treatment based on ciculating tumour cell DNA variants improves outcomes. That will take years.The story is intact. The sky is blue. But there is no meat and this company still needs money to keep going.
04-01-2024
Chart pointing to the stars.
Here's how I see the coming days playing out.....
Today - 36-40p
Friday - 55p
Next week, we get to £1
At some point in January we get a very generous takeover bid from Astrazeneca.
They can have my shares at £2.75
20-12-2023
Bound to be a New Year share TIP for ANGLE - so undervalued and a red hot takeover prospect!
14-11-2023
Bargain down here - prime takeover candidate by US Pharma
BUY
26-10-2023
Current cash (inc R&D credits) likely to be around £20.1m. Current market cap £28.7m. Enterprise value now around £8m. Angle really is ripe for a takeover bid - why partner, when you can acquire.